Video

Prostate Cancer Advances From the Past 10 Years

Author(s):

Robert Dreicer, MD

Robert Dreicer, MD from the Taussig Cancer Institute Examines Prostate Cancer Advances From the Past 10 Years

Related Videos
Julia Foldi, MD, PhD
Joaquim Bellmunt, MD, PhD
Brandon Huffman, MD
Lakshmi Nayak, MD
John Burke, MD
Justin M. Watts, MD
Rohan Garje, MD
Manmeet Ahluwalia, MD, MBA, FASCO
Jakub Svoboda, MD
Suneel Kamath, MD
Related Content
Michael J. Morris, MD
June 10th 2024

JNJ-6420 Elicits Responses in mCRPC, But Safety Concerns Arise

Neeraj Agarwal, MD
July 17th 2023

FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC

Fernando Cotait Maluf, MD
June 7th 2024

Pembrolizumab With Platinum-Based Therapy is Safe and Efficacious in PSCC

Andrew J. Armstrong, MD, MSc
June 15th 2023

FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

Stephen J. Freedland, MD
June 5th 2024

Enzalutamide Treatment Suspension Has No Significant Impact on QOL in nmHSPC

Philip Sutera, MD, of Johns Hopkins University School of Medicine
May 30th 2024

PSMA Response Is Associated With MFS Improvement in Oligometastatic CSPC